CytoMed Therapeutics (GDTC) Total Non-Current Liabilities (2021 - 2026)
CytoMed Therapeutics (GDTC) posted Total Non-Current Liabilities of $391,715 for Q2 2026, down 9.3% from $431,769 a year earlier.
Powered by 
Analysis
CytoMed Therapeutics (GDTC) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends
At the end of FY2025, CytoMed Therapeutics' Total Non-Current Liabilities came in at $323,088, up 3.4% from FY2024.
- Annual Total Non-Current Liabilities shows a four-year compound annual growth rate of -5.9% (FY2021 to FY2025).
- In prior years, CytoMed Therapeutics' Total Non-Current Liabilities was $312,423 in FY2024 (+2.9%), $303,714 in FY2023 (-12.0%), $345,058 in FY2022 (-16.4%) and $412,749 in FY2021.
- Quarterly Total Non-Current Liabilities has run from a low of $302,034 in Q4 2023 to a high of $431,769 in Q2 2025 over five years.
- On a year-over-year basis, Total Non-Current Liabilities increased in three of the last four quarters, with growth averaging 2.2%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 97.04 Bn |
| 10 | CytoMed Therapeutics | 9.44 Mn | -158,924.18 | - | 391,715.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 391,715.00 |
| Dec 31, 2025 | 328,777.16 |
| Jun 30, 2025 | 431,769.00 |
| Dec 31, 2024 | 307,030.99 |
| Jun 30, 2024 | 390,896.00 |
| Dec 31, 2023 | 308,964.99 |
| Jun 30, 2023 | 431,195.00 |
| Dec 31, 2022 | 353,947.83 |
| Dec 31, 2021 | 410,113.85 |
API Access
CytoMed Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=GDTC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "GDTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=GDTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();